pipette
ENEnglish

Orthosteric and allosteric inhibition of the brain V-ATPase outside the alternating-access cycle

Eleftherios Kosmidis, Maria Fokaeos, Christopher G. Shuttle, Michael Isselstein, Alessandra Narducci, Aleksander Cvjetkovic, Peter J. Johnson, Jesper Lund Pedersen, Reinhard Jahn, Julia Preobraschenski, Dimitrios G. Stamou

Revista con revisión por paresAfirmaciones fuertes, leer con cuidado

En palabras de los autores

Active transporters move solutes uphill by harnessing the free energy stored in ATP or ion-motive gradients. A central tenet of molecular pharmacology is that orthosteric and allosteric inhibitors of active transporters act by slowing the transport cycle. We test this foundational premise, previously supported by ensemble-average data, at the single-molecule level. Using endogenous mammalian-brain V-ATPase, we show that bulk acidification can be abolished without any reduction in the single-molecule proton-transport rate. Instead, inhibitors predominantly promote reversible excursions outside the canonical transport cycle into ultralong-lived inactive modes. Overall, our findings establish the existence of two orthogonal axes of pharmacological control (on-cycle catalytic rates and off-cycle mode occupancy) that can be selectively or jointly actuated for precision drug design and likely generalize to other active transporters. V-ATPases are proton pumps that acidify synaptic vesicles and intracellular compartments. Here, authors show that several inhibitors mainly switch individual brain V-ATPases into long-lived inactive states instead of slowing proton pumping rates.

Resultado principalEl resumen no menciona limitaciones.

Apareció: miércoles, 30 de septiembre. Nature Communications. Revista con revisión por pares.

DOI: 10.1038/s41467-026-78028-4